The simpler kinds of tests for antibodies won't work.
Two weeks ago we issued an alert to blood banks.
It's a very, very important question.
We are enthusiastic about the potential of having a very accurate, simple test in the home to increase testing and awareness in people about their HIV status. But we are seeking broad input from our panel and the public on the benefits and any risks.
This approval is the result of a tremendous cooperative effort among FDA, other public health agencies, the test kit manufacturers and the blood industry.
We are pleased that the Chiron Corp. has taken steps to address issues at their facility in Liverpool as they prepare for the upcoming flu season.
That doesn't mean it's acceptable, but we need to keep the risk in perspective.
That's been an area of a lot of research, ... promising technologies.